WPD Pharmaceuticals Inc. (CSE: WBIO)
Canada flag Canada · Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Nov 18, 2024, 9:30 AM EST

WPD Pharmaceuticals Statistics

Total Valuation

WPD Pharmaceuticals has a market cap or net worth of CAD 579,936. The enterprise value is 917,665.

Market Cap 579,936
Enterprise Value 917,665

Important Dates

The next estimated earnings date is Friday, November 29, 2024.

Earnings Date Nov 29, 2024
Ex-Dividend Date n/a

Share Statistics

WPD Pharmaceuticals has 115.99 million shares outstanding. The number of shares has increased by 0.08% in one year.

Current Share Class n/a
Shares Outstanding 115.99M
Shares Change (YoY) +0.08%
Shares Change (QoQ) +0.31%
Owned by Insiders (%) 22.38%
Owned by Institutions (%) 0.54%
Float 77.94M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -6.55
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.08

Current Ratio 0.08
Quick Ratio 0.07
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -5.13

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -69.56%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -8,755
Employee Count 16
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -88.89% in the last 52 weeks. The beta is 0.76, so WPD Pharmaceuticals's price volatility has been lower than the market average.

Beta (5Y) 0.76
52-Week Price Change -88.89%
50-Day Moving Average 0.01
200-Day Moving Average 0.02
Relative Strength Index (RSI) 25.75
Average Volume (20 Days) 32,550

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -306,620
Pretax Income -140,079
Net Income -140,079
EBITDA -310,104
EBIT -306,620
Earnings Per Share (EPS) -0.00
Full Income Statement

Balance Sheet

The company has 3,054 in cash and 340,780 in debt, giving a net cash position of -337,726 or -0.00 per share.

Cash & Cash Equivalents 3,054
Total Debt 340,780
Net Cash -337,726
Net Cash Per Share -0.00
Equity (Book Value) -675,642
Book Value Per Share -0.01
Working Capital -559,335
Full Balance Sheet

Cash Flow

Operating Cash Flow -186,043
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

WPD Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.08%
Shareholder Yield -0.08%
Earnings Yield -24.66%
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a